NCT00018954View on ClinicalTrials.gov

Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1992

Study Completion Date

October 31, 2002

Conditions
LeukemiaLymphoma
Interventions
DRUG

asparaginase

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

daunorubicin hydrochloride

DRUG

doxorubicin hydrochloride

DRUG

etoposide

DRUG

ifosfamide

DRUG

mercaptopurine

DRUG

methotrexate

DRUG

prednisone

DRUG

vincristine sulfate

PROCEDURE

conventional surgery

RADIATION

radiation therapy

Trial Locations (5)

400012

Tata Memorial Centre, Mumbai

560029

Kidwai Memorial Institute of Oncology, Bangalore

600020

Cancer Institute (W.I.A.), Madras

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

Unknown

National Cancer Institute of Egypt, Cairo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00018954 - Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter